Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease

PHASE3TerminatedINTERVENTIONAL
Enrollment

560

Participants

Timeline

Start Date

July 31, 2001

Study Completion Date

June 30, 2004

Conditions
Peripheral Vascular Disease
Interventions
DRUG

Ecraprost in lipid emulsion

Trial Locations (27)

Unknown

Phoenix

Tucson

Glendale

Los Angeles

Pasadena

San Francisco

Pensacola

Springfield

Indianapolis

New Orleans

Royal Oak

Biloxi

Kansas City

Henderson

West Caldwell

New York

Charlotte

Portland

San Antonio

Tacoma

Birmingham

Bristol

Dundee

Hull

London

Manchester

Southhampton

All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY